Zacks Investment Research
02 Mar 2026, 15:56 UTC · 34w ago
Impact · against what's priced in
BioLife Solutions shows strong bullish signals based on high analyst consensus and positive earnings revisions. While recent price momentum is evident, the gap between the current price and the mean target suggests further upside potential.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
Wall Street analysts have a mean short-term price target of $32.67 for BioLife Solutions (BLFS), representing a potential 35% upside from its current price of $24.2.
So whatA significant gap between current price and consensus target suggests bullish sentiment and potential for price appreciation.
More positive than 77% of claims this week
There is strong agreement among analysts regarding positive earnings estimate revisions for BioLife Solutions.
Continue reading
5 related stories
Wall Street analysts show strong agreement on a mean price target of $32.67, implying a 35% upside from the current $24.2 price, supported by positive earnings estimate revisions.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 63% of claims this week
BioLife Solutions shares have increased 11% over the past four weeks.
More positive than 41% of claims this week
Which stocks this story touches
More positive than 89% of ticker scores this week
The stock has gained 11% recently and has strong analyst agreement on potential upside and positive earnings revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
2h ago
+59.5%
Price agrees with the score
$38.61 vs $24.20 close before publication (Feb 27) · not market-adjusted
BLFS chart →
